Cytosine Arabinoside Injection

Cytosine Arabinoside Injection Specification

Indication
Used in the treatment of certain cancers, particularly leukemia

Dosage Form
Injection

Salt Composition
Cytosine Arabinoside (Cytarabine)

Origin
Pharmaceutical Grade

Ingredients
Cytarabine, Water for Injection, buffering agents

Application

Physical Color/Texture
Clear, colorless solution

Fermentation Smell
Odorless

Shelf Life
24 months from date of manufacture

Dilution
If required, dilute with compatible infusion solutions

Latex Free
Yes

Route of Administration
Intravenous (IV) or subcutaneous

Strength
100 mg/ml or as specified on the vial

Packaging Type
Glass vial, sealed under aseptic conditions

USP Compliance
Meets official compendial standards

Microbiological Testing
Sterility and endotoxin tested

Avoid Freezing
Do not freeze

Cytosine Arabinoside Injection Trade Information

Supply Ability
1000 Pieces Per Week

Delivery Time
1 Week

About Cytosine Arabinoside Injection

Cytosin arabinoside

Cytarabine, or cytosine arabinoside, is a chemotherapy agent used mainly in the treatment of cancers of white blood cells such as acute myeloid leukemia (AML) and non-Hodgkin lymphoma.[1] It is also known as Ara-C (Arabinofuranosyl Cytidine).[2] It kills cancer cells by interfering with DNA synthesis.

It is called cytosine arabinoside because it combines a cytosine base with an arabinose sugar. Cytosine normally combines with a different sugar, deoxyribose, to form deoxycytidine, a component of DNA. Certain sponges, where it was originally found, use arabinoside sugars to form a different compound (not part of DNA). Cytosine arabinoside is similar enough to human cytosine deoxyribose (deoxycytidine) to be incorporated into human DNA, but different enough that it kills the cell. This mechanism is used to kill cancer cells. Cytarabine is the first of a series of cancer drugs that altered the sugar component of nucleosides.

Targeted Cancer Therapy

This injection is especially effective in the treatment of hematological malignancies such as leukemia, acting by inhibiting DNA synthesis in rapidly dividing cancerous cells. Cytarabine is a cornerstone agent in chemotherapy protocols, helping to induce remission and extend patient survival in challenging oncological conditions.

Rigorous Quality and Safety Standards

Cytosine Arabinoside Injection complies with all applicable USP (United States Pharmacopeia) guidelines, ensuring meticulous microbiological testing for sterility and endotoxin levels. Each glass vial is prepared under recorded aseptic conditions to guarantee patient safety while maintaining efficacy throughout the 24-month shelf life.

Flexible Administration and Application

The injection can be delivered intravenously or subcutaneously, allowing flexibility in treatment protocol based on clinical requirements. Its clear, colorless solution is easy to prepare and, if required, can be diluted with standard infusion fluids. This makes it suitable for various clinical settings, including both inpatient and outpatient care centers.

FAQs of Cytosine Arabinoside Injection:

Q: How is Cytosine Arabinoside Injection administered?

A: Cytosine Arabinoside Injection is administered either intravenously or subcutaneously by a trained healthcare professional. The route depends on your doctors recommendations and the specific treatment protocol.

Q: What types of cancers is this injection typically used to treat?

A: This medication is primarily used in the treatment of certain blood cancers, especially leukemias. It works by inhibiting DNA synthesis in rapidly dividing cancer cells, aiding in remission and disease control.

Q: When should the injection be diluted, and with what solutions?

A: Dilution is only necessary if specified by your healthcare provider. If required, use compatible infusion solutions as recommended for cytarabine injections; always follow clinical guidelines for preparation.

Q: Where should Cytosine Arabinoside Injection be stored?

A: Store the unopened vials at temperatures below 25C. Do not freeze the product, as freezing may compromise its integrity. Always keep it in its original packaging until use.

Q: What safety checks are performed on this product?

A: The injection undergoes strict sterility and endotoxin testing, complies with USP standards, and is prepared under aseptic conditions. Each vial is latex-free, ensuring safe use for patients with latex sensitivities.

Q: What are the benefits of using Cytosine Arabinoside Injection in chemotherapy?

A: This medication is a powerful agent for treating leukemia, with proven efficacy in inducing remission and managing cancer progression. Its pharmaceutical-grade formulation assures reliable quality and safety.